Ozpharm Limited - Period Ending 2017-08-31

Ozpharm Limited - Period Ending 2017-08-31


Ozpharm Limited 02299269 false 2016-09-01 2017-08-31 2017-08-31 The principal activity of the company is pharmacy Digita Accounts Production Advanced 6.21.8540.0 Software true 02299269 2016-09-01 2017-08-31 02299269 2017-08-31 02299269 bus:OrdinaryShareClass1 2017-08-31 02299269 core:RetainedEarningsAccumulatedLosses 2017-08-31 02299269 core:ShareCapital 2017-08-31 02299269 core:CurrentFinancialInstruments 2017-08-31 02299269 core:CurrentFinancialInstruments core:WithinOneYear 2017-08-31 02299269 core:FurnitureFittingsToolsEquipment 2017-08-31 02299269 core:LandBuildings 2017-08-31 02299269 bus:SmallEntities 2016-09-01 2017-08-31 02299269 bus:AuditExemptWithAccountantsReport 2016-09-01 2017-08-31 02299269 bus:FullAccounts 2016-09-01 2017-08-31 02299269 bus:RegisteredOffice 2016-09-01 2017-08-31 02299269 bus:CompanySecretaryDirector1 2016-09-01 2017-08-31 02299269 bus:Director2 2016-09-01 2017-08-31 02299269 bus:OrdinaryShareClass1 2016-09-01 2017-08-31 02299269 bus:PrivateLimitedCompanyLtd 2016-09-01 2017-08-31 02299269 core:FurnitureFittings 2016-09-01 2017-08-31 02299269 core:FurnitureFittingsToolsEquipment 2016-09-01 2017-08-31 02299269 core:LandBuildings 2016-09-01 2017-08-31 02299269 countries:England 2016-09-01 2017-08-31 02299269 2016-08-31 02299269 core:FurnitureFittingsToolsEquipment 2016-08-31 02299269 core:LandBuildings 2016-08-31 02299269 2015-09-01 2016-08-31 02299269 2016-08-31 02299269 bus:OrdinaryShareClass1 2016-08-31 02299269 core:RetainedEarningsAccumulatedLosses 2016-08-31 02299269 core:ShareCapital 2016-08-31 02299269 core:CurrentFinancialInstruments 2016-08-31 02299269 core:CurrentFinancialInstruments core:WithinOneYear 2016-08-31 02299269 core:FurnitureFittingsToolsEquipment 2016-08-31 02299269 core:LandBuildings 2016-08-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 02299269

Ozpharm Limited

Annual Report and Unaudited Financial Statements

for the Year Ended 31 August 2017

Wall and Partners
Chartered Accountants
3 & 5 Commercial Gate
Mansfield
Nottinghamshire
NG18 1EJ

 

Ozpharm Limited

Contents

Company Information

1

Balance Sheet

2 to 3

Notes to the Financial Statements

4 to 8

 

Ozpharm Limited

Company Information

Directors

Mr P Oza

Mrs P Oza

Company secretary

Mr P Oza

Registered office

50 Lowmoor Road
Kirkby in Ashfield
Nottingham
Nottinghamshire
NG17 7BG

Accountants

Wall and Partners
Chartered Accountants
3 & 5 Commercial Gate
Mansfield
Nottinghamshire
NG18 1EJ

 

Ozpharm Limited

(Registration number: 02299269 )
Balance Sheet as at 31 August 2017

Note

2017
£

2016
£

Fixed assets

 

Tangible assets

4

64,493

21,301

Investment property

5

1,322,129

1,322,129

 

1,386,622

1,343,430

Current assets

 

Stocks

6

60,000

56,500

Debtors

7

143,955

323,246

Cash at bank and in hand

 

4,221,383

3,685,678

 

4,425,338

4,065,424

Creditors: Amounts falling due within one year

8

(251,733)

(423,031)

Net current assets

 

4,173,605

3,642,393

Total assets less current liabilities

 

5,560,227

4,985,823

Provisions for liabilities

(3,375)

(616)

Net assets

 

5,556,852

4,985,207

Capital and reserves

 

Called up share capital

100

100

Profit and loss account

5,556,752

4,985,107

Total equity

 

5,556,852

4,985,207

For the financial year ending 31 August 2017 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

 

Ozpharm Limited

(Registration number: 02299269 )
Balance Sheet as at 31 August 2017

Approved and authorised by the Board on 28 June 2018 and signed on its behalf by:
 

Mr P Oza

Company secretary and director

 

Ozpharm Limited

Notes to the Financial Statements for the Year Ended 31 August 2017

1

General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
50 Lowmoor Road
Kirkby in Ashfield
Nottingham
Nottinghamshire
NG17 7BG

These financial statements were authorised for issue by the Board on 28 June 2018.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

The Company's financial statements are presented in pounds sterling (£) which is also the Company's functional currency, and all values are rounded to the nearest pound.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

Foreign currency transactions and balances

Transactions in foreign currencies are initially recorded at the functional currency rate prevailing at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are retranslated into the respective functional currency of the entity at the rates prevailing on the reporting period date. Non-monetary items carried at fair value that are denominated in foreign currencies are retranslated at the rates prevailing on the initial transaction dates.

Non-monetary items measured in terms of historical cost in a foreign currency are not translated.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a charge attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

 

Ozpharm Limited

Notes to the Financial Statements for the Year Ended 31 August 2017

The current corporation tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Improvements to property

5% straight line

Fixture and fittings

15% reducing balance

Investment property

Investment property is carried at fair value, derived from the current market prices for comparable real estate determined annually by external valuers. The valuers use observable market prices, adjusted if necessary for any difference in the nature, location or condition of the specific asset. Changes in fair value are recognised in profit or loss.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

 

Ozpharm Limited

Notes to the Financial Statements for the Year Ended 31 August 2017

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 10 (2016 - 9).

 

Ozpharm Limited

Notes to the Financial Statements for the Year Ended 31 August 2017

4

Tangible assets

Improvements to property
£

Fixtures and fittings
£

Total
£

Cost or valuation

At 1 September 2016

29,790

44,497

74,287

Additions

31,084

17,290

48,374

At 31 August 2017

60,874

61,787

122,661

Depreciation

At 1 September 2016

12,076

40,910

52,986

Charge for the year

2,484

2,698

5,182

At 31 August 2017

14,560

43,608

58,168

Carrying amount

At 31 August 2017

46,314

18,179

64,493

At 31 August 2016

17,714

3,587

21,301

Included within the net book value of land and buildings above is £46,314 (2016 - £17,714) in respect of freehold land and buildings.
 

5

Investment properties

2017
£

At 1 September

1,322,129

There has been no valuation of investment property by an independent valuer.

6

Stocks

2017
£

2016
£

Other inventories

60,000

56,500

7

Debtors

2017
£

2016
£

Trade debtors

121,069

124,003

Prepayments

4,952

6,127

Other debtors

17,934

193,116

143,955

323,246

 

Ozpharm Limited

Notes to the Financial Statements for the Year Ended 31 August 2017

8

Creditors

Creditors: amounts falling due within one year

2017
£

2016
£

Due within one year

Trade creditors

104,926

90,039

Taxation and social security

535

576

Accruals and deferred income

7,944

9,206

Other creditors

138,328

323,210

251,733

423,031

9

Share capital

Allotted, called up and fully paid shares

 

2017

2016

 

No.

£

No.

£

Ordinary of £1 each

100

100

100

100

         

10

Related party transactions

Directors' remuneration

The directors' remuneration for the year was as follows:

2017
£

2016
£

Remuneration

8,750

9,100